IBDEI15Q ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,19682,1,4,0)
 ;;=4^R09.81
 ;;^UTILITY(U,$J,358.3,19682,2)
 ;;=^5019203
 ;;^UTILITY(U,$J,358.3,19683,0)
 ;;=I69.928^^84^920^22
 ;;^UTILITY(U,$J,358.3,19683,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19683,1,3,0)
 ;;=3^Speech/Lang Deficit Following Cerebvasc Disease
 ;;^UTILITY(U,$J,358.3,19683,1,4,0)
 ;;=4^I69.928
 ;;^UTILITY(U,$J,358.3,19683,2)
 ;;=^5007557
 ;;^UTILITY(U,$J,358.3,19684,0)
 ;;=I69.328^^84^920^23
 ;;^UTILITY(U,$J,358.3,19684,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19684,1,3,0)
 ;;=3^Speech/Lang Deficit Following Cerebvasc Infarc
 ;;^UTILITY(U,$J,358.3,19684,1,4,0)
 ;;=4^I69.328
 ;;^UTILITY(U,$J,358.3,19684,2)
 ;;=^5007495
 ;;^UTILITY(U,$J,358.3,19685,0)
 ;;=E04.0^^84^921^39
 ;;^UTILITY(U,$J,358.3,19685,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19685,1,3,0)
 ;;=3^Nontoxic Diffuse Goiter
 ;;^UTILITY(U,$J,358.3,19685,1,4,0)
 ;;=4^E04.0
 ;;^UTILITY(U,$J,358.3,19685,2)
 ;;=^5002477
 ;;^UTILITY(U,$J,358.3,19686,0)
 ;;=E04.1^^84^921^41
 ;;^UTILITY(U,$J,358.3,19686,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19686,1,3,0)
 ;;=3^Nontoxic Single Thyroid Nodule
 ;;^UTILITY(U,$J,358.3,19686,1,4,0)
 ;;=4^E04.1
 ;;^UTILITY(U,$J,358.3,19686,2)
 ;;=^5002478
 ;;^UTILITY(U,$J,358.3,19687,0)
 ;;=E04.2^^84^921^40
 ;;^UTILITY(U,$J,358.3,19687,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19687,1,3,0)
 ;;=3^Nontoxic Multinodular Goiter
 ;;^UTILITY(U,$J,358.3,19687,1,4,0)
 ;;=4^E04.2
 ;;^UTILITY(U,$J,358.3,19687,2)
 ;;=^267790
 ;;^UTILITY(U,$J,358.3,19688,0)
 ;;=E01.1^^84^921^36
 ;;^UTILITY(U,$J,358.3,19688,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19688,1,3,0)
 ;;=3^Iodine-Deficiency Related Multinodular (Endemic) Goiter
 ;;^UTILITY(U,$J,358.3,19688,1,4,0)
 ;;=4^E01.1
 ;;^UTILITY(U,$J,358.3,19688,2)
 ;;=^5002465
 ;;^UTILITY(U,$J,358.3,19689,0)
 ;;=E05.00^^84^921^56
 ;;^UTILITY(U,$J,358.3,19689,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19689,1,3,0)
 ;;=3^Thyrotoxicosis w/ Diffuse Goiter w/o Thyrotoxic Crisis
 ;;^UTILITY(U,$J,358.3,19689,1,4,0)
 ;;=4^E05.00
 ;;^UTILITY(U,$J,358.3,19689,2)
 ;;=^5002481
 ;;^UTILITY(U,$J,358.3,19690,0)
 ;;=E05.01^^84^921^55
 ;;^UTILITY(U,$J,358.3,19690,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19690,1,3,0)
 ;;=3^Thyrotoxicosis w/ Diffuse Goiter w/ Thyrotoxic Crisis/Storm
 ;;^UTILITY(U,$J,358.3,19690,1,4,0)
 ;;=4^E05.01
 ;;^UTILITY(U,$J,358.3,19690,2)
 ;;=^5002482
 ;;^UTILITY(U,$J,358.3,19691,0)
 ;;=E05.90^^84^921^58
 ;;^UTILITY(U,$J,358.3,19691,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19691,1,3,0)
 ;;=3^Thyrotoxicosis,Unspec w/o Thyrotoxic Crisis/Storm
 ;;^UTILITY(U,$J,358.3,19691,1,4,0)
 ;;=4^E05.90
 ;;^UTILITY(U,$J,358.3,19691,2)
 ;;=^5002492
 ;;^UTILITY(U,$J,358.3,19692,0)
 ;;=E05.91^^84^921^57
 ;;^UTILITY(U,$J,358.3,19692,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19692,1,3,0)
 ;;=3^Thyrotoxicosis,Unspec w/ Thyrotoxic Crisis/Storm
 ;;^UTILITY(U,$J,358.3,19692,1,4,0)
 ;;=4^E05.91
 ;;^UTILITY(U,$J,358.3,19692,2)
 ;;=^5002493
 ;;^UTILITY(U,$J,358.3,19693,0)
 ;;=E89.0^^84^921^50
 ;;^UTILITY(U,$J,358.3,19693,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19693,1,3,0)
 ;;=3^Postprocedural Hypothyroidism
 ;;^UTILITY(U,$J,358.3,19693,1,4,0)
 ;;=4^E89.0
 ;;^UTILITY(U,$J,358.3,19693,2)
 ;;=^5003035
 ;;^UTILITY(U,$J,358.3,19694,0)
 ;;=E03.2^^84^921^32
 ;;^UTILITY(U,$J,358.3,19694,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19694,1,3,0)
 ;;=3^Hypothyroidism d/t Meds/Oth Exogenous Substances
 ;;^UTILITY(U,$J,358.3,19694,1,4,0)
 ;;=4^E03.2
 ;;^UTILITY(U,$J,358.3,19694,2)
 ;;=^5002471
 ;;^UTILITY(U,$J,358.3,19695,0)
 ;;=E03.9^^84^921^33
